Methocarbamol Injection, Solution
Product Images NDC 25021-689

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methocarbamol (NDC 25021-689). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Met1o 0000 01)

Structural Formula (Met1o 0000 01)
Chemical structure diagram of Methocarbamol, showing the arrangement of atoms and bonds within the molecule for this active ingredient.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Met1o 0000 02)

Package Label – Principal Display Panel – Vial Label (Met1o 0000 02)
Methocarbamol Injection, USP 100 mg/mL, 1000 mg per 10 mL single-dose vial labeled for intravenous or intramuscular injection. The label from Sagent Pharmaceuticals includes directions for intravenous and intramuscular use, storage instructions, and warnings against mixing with intravenous infusion fluids. Made in India and distributed by Sagent Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.